Bilateral Synchronous Phyllodes Tumors with Differing Grades and Misleading Axillary 18F-FDG PET-CT Uptake: A Case Study and Review of the Literature - Report - MDSpire
Advertisement
Bilateral Synchronous Phyllodes Tumors with Differing Grades and Misleading Axillary 18F-FDG PET-CT Uptake: A Case Study and Review of the Literature
Clinical Report: Bilateral Synchronous Phyllodes Tumors with Differing Grades
Overview
This report discusses a rare case of synchronous bilateral phyllodes tumors in a 44-year-old woman, highlighting the diagnostic challenges posed by 18F-FDG PET-CT imaging. The findings emphasize the importance of clinicopathologic correlation in managing phyllodes tumors, particularly regarding axillary lymph node assessment.
Background
Phyllodes tumors are rare fibroepithelial neoplasms of the breast, accounting for a small percentage of breast tumors. Their variable biological behavior and potential for local recurrence or metastasis necessitate careful management. Synchronous bilateral phyllodes tumors are exceptionally rare, complicating diagnosis and treatment, particularly when imaging may misinterpret reactive changes as malignancy.
Data Highlights
Parameter
Left Breast Mass
Right Breast Nodule
SUVmax
11.5
1.7
Elastography Score
4
2
Final Pathology
Borderline Phyllodes Tumor
Benign Phyllodes Tumor
Axillary Lymph Nodes
Reactive Hyperplasia
N/A
Key Findings
Incorporate a finding regarding the patient's clinical presentation and treatment outcomes.
Clinical Implications
Clinicians should be cautious when interpreting 18F-FDG PET-CT results in the context of phyllodes tumors, as reactive changes may mimic metastasis. Surgical management should prioritize complete excision with negative margins, and axillary surgery should be guided by clinical and pathological findings rather than imaging alone.
Conclusion
This case underscores the complexities of diagnosing and managing synchronous bilateral phyllodes tumors, particularly regarding imaging interpretation and axillary assessment. A multidisciplinary approach is essential for optimal patient outcomes.